Cargando…
Insulin insulated: barriers to competition and affordability in the United States insulin market
Insulin prices in the United States are skyrocketing. In addition to several challenges common to high-priced prescription drugs, insulin faces several unique legal, regulatory, and practical challenges to increasing access and affordability. Despite the fact that insulin was developed almost 100 ye...
Autor principal: | Knox, Ryan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8249113/ https://www.ncbi.nlm.nih.gov/pubmed/34221426 http://dx.doi.org/10.1093/jlb/lsaa061 |
Ejemplares similares
-
Navigating barriers to affording and obtaining insulin and diabetes supplies
por: Wilcox, Annabelle E., et al.
Publicado: (2022) -
Lower barriers to primary care after the implementation of the Affordable Care Act in the United States of America
por: Bustamante, Arturo Vargas, et al.
Publicado: (2018) -
The insulin market reaches 100
por: Beran, David, et al.
Publicado: (2022) -
Can nutrition interventions tackle the global insulin affordability via improving diabetes management and reducing insulin demand?
por: Lu, Victoria, et al.
Publicado: (2022) -
Limb apraxia and the “affordance competition hypothesis”
por: Rounis, Elisabeth, et al.
Publicado: (2015)